Skip to main content
. 2012 Oct;78(20):7420–7428. doi: 10.1128/AEM.01502-12

Fig 2.

Fig 2

Ethidium bromide-stained 2.0% agarose gel showing amplification products obtained with TRAP-C2 primers from feces and GI tract samples from H. schlegeli. Lane 1, 100-bp molecular marker; lane 2, negative control (with IC); lane 4, fecal sample 1 day after exposure to oocysts; lane 6, fecal sample 3 days after exposure to oocysts; lane 8, fecal sample 5 days after exposure to oocysts; lane 10, GI tract sample 1 day after exposure to oocysts; lane 12, GI tract sample 3 days after exposure to oocysts; lane 14, GI tract sample 5 days after exposure to oocysts; lane 16, positive control; lane 17, 100-bp molecular marker.